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Volume 57, Number 5S Abstracts 7SObjectives: The impact of severe (>70%) contralateral
carotid stenosis or occlusion (SCSO) on outcomes
following carotid endarterectomy (CEA) is controversial.
This study evaluated the effect of SCSO on outcomes
following CEA.
Methods: All patients undergoing carotid endarterec-
tomy at a single institution were retrospectively stratiﬁed
according to the presence of SCSO. The peri-operative
outcomes of CEA in the presence of SCSO were analyzed
using univariate and multivariable methods.
Results: There were 2945 CEA performed from 1/89
to 1/06, including 736 (25%) patients with SCSO. Patients
identiﬁed with SCSO had a higher rate of prior contralat-
eral CEA (44% vs 21%; P < .01), positive intra-operative
EEG changes (31% vs 17%; P < .01), and use of an intra-
operative shunt (40% vs 28%; P < .01). Univariate analysis
identiﬁed SCSO as a risk factor for any stroke (2.8% vs
1.5%; P ¼ .02), death (2.2% vs 1.1%; P ¼ .03), and any
stroke/death (4.3% vs 2.4%; P < .01), but not ipsilateral
stroke (1.6% vs 1.2%; P ¼ .4). Multivariable regression
demonstrated SCSO as an independent predictor of any
stroke (OR1.8 [95% CI: 1-3.3]; P ¼ .05) and any
stroke/death (OR1.7[95% CI: 1.1-2.7]; P ¼ .02), without
increasing risk of ipsilateral stroke (OR1.3[95% CI:
0.6-2.7]; P ¼ .2). The presence of SCSO was also associ-
ated with a higher risk of late mortality (HR1.3 [95% CI:
1.1-1.4]; P < .01).
Conclusions: Although the presence of SCSO is a risk
factor for any stroke/death with CEA, it does not increase
the risk of ipsilateral stroke. These data suggest that
increased attention to peri-operative medical and hemody-
namic management should be especially considered in this
patient cohort as the observed strokes do not occur in the
territory at risk from the surgical procedure.
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Patients With Occlusive and Aneurysmal Vascular
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Panos Kougias1, Briauna Lowery1, Sherene Sharath1, Peter
H. Lin2, Carlos Bechara1, George Pisimisis1, Taemee Pak2,
Neal R. Barshes1. 1Surgery, Michael E. DeBakey VAMC,
Houston, Tex; 2Baylor College of Medicine, Houston, Tex
Objectives: Patients with occlusive or aneurysmal
vascular disease are repeatedly exposed to intravenous
(IV) contrast for diagnostic or therapeutic purposes. We
sought to determine the long-term impact of cumulative
iodinated IV contrast exposure (CIVCE) on renal func-
tion, the later deﬁned with National Kidney Foundation
(NKF) criteria.
Methods: We conducted a longitudinal analysis on
consecutive patients without renal insufﬁciency at baseline
(NFK stage I or II) who underwent interventions forarterial occlusive or aneurysmal disease. We collected
detailed data on any IV iodinated contrast exposure
(including diagnostic or therapeutic angiography, cardiac
catheterization, IV pyelography, computed tomography
(CT) with IV contrast, and CT angiography); medication
exposure throughout the observation period; comorbid-
ities; and demographics. Primary end point was the devel-
opment of renal failure (RF) (deﬁned as NFK stage 4 or 5).
Analysis was performed using a Cox Regression frailty
model with clustering at the patient level.
Results: Patients (n ¼ 1298) had a mean follow-up of
5.8 (range, 2.2-14) years. In the multivariate model with
RF as dependent variable and after adjusting for the statis-
tically signiﬁcant covariates of baseline renal function (HR,
0.94; P < .001), age (HR, 0.42; P < .001), diabetes (HR,
2.2; P ¼ .013), and congestive heart failure (HR, 3.2; P <
.001), CIVCE remained an independent predictor of RF
development (HR, 1.15; P < .001). In the multivariate
survival analysis model and after adjusting for the statisti-
cally signiﬁcant covariates of the newly developed RF
(HR, 5.1; P < .001), perioperative myocardial infarction
(HR, 5.2; P ¼ .004), age (HR, 1.5; P ¼ .01), total number
of open operations (HR, 2.1; P < .001) and serum
albumin (HR, 0.4; P < .001), CIVCE was an independent
predictor of mortality (HR, 1.14; P < .001).
Conclusions: Cumulative IV iodinated contrast expo-
sure is an independent predictor of renal failure and
mortality in patients with occlusive and aneurysmal vascular
disease.
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Objectives: Lower extremity vein bypass grafts
(LEVBG) undergo geometric remodeling within the ﬁrst
month of surgery which directly correlates with subsequent
patency. Veins are less vasoreactive than arteries and the
extent of biochemical adaptation by vein grafts in the arterial
environment is unknown. Flow-mediated vasodilation
(FMD) measures endothelial-dependent vasodilation in
response to hyperemia. We hypothesized that geometric
remodeling of venous conduits would be correlated with
endothelial function after LEVBG.
Methods: Patients undergoing LEVBG were prospec-
tively enrolled. Brachial artery FMD was performed at
baseline and vein graft FMD studies were performed at
intervals following LEVBG.
Results: A total of 57 patients, median age 64 years
(IQR, 61-71) with median follow-up 17 months (IQR,
10-32), were included. Most patients (91%) were male, 75%
were white, 49% had diabetes, 81% were on a statin and the
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vein grafts (68%) were single-segment great saphenous vein
and 63% were femoral-popliteal bypasses. Mean baseline
brachial artery FMD was 7.6 6 4.5%. Mean graft lumen
diameter increased from 4.3 6 0.8 mm at surgery to 4.7 6
0.8 mm at 3 months. There was a signiﬁcant correlation
between initial lumen diameter and 0-3 months remodeling
(r¼.48;P¼ .02).No correlationwas seenbetween brachial
FMD and vein graft FMD. Mature ($12 months) grafts had
signiﬁcantly higher FMD than early (3 months) grafts (4.56
2.7% vs 0.6 6 1.9%; P < .0005) and there was a signiﬁcant
positive correlation between early and late graft FMD (r ¼
.64; P ¼ .01). We did not observe a signiﬁcant correlation
between early graft remodeling and either brachial or vein
graft FMD.
Conclusions: LEVBG patients have endothelial
dysfunction demonstrated by impaired brachial artery
FMD. Veins grafts exhibit recovery of endothelial function
over the ﬁrst year of implantation. However, early
geometric remodeling appears asynchronous from physio-
logic endothelial recovery in the aterialized vein.
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Objectives: The Society for Vascular Surgery’s Objec-
tive Performance Goals (SVS OPGs) for critical limb
ischemia (CLI) are derived from bypass surgery outcomes
in a pooled cohort from 3 randomized trials. We examine
the effectiveness of endovascular therapy (ET) for CLI in
using OPG efﬁcacy benchmarks.
Methods: CLI patients undergoing ET (2006-2012),
were identiﬁed in a prospectively maintained database.
Unadjusted outcomes were used for comparisons to theTable. One year results with endovascular therapy compared
Outcome metric
Overall
OPG (n ¼ 838) Endo (n ¼
Major adverse limb event or post-op death (MALE +
POD)
71% 73 6 3%
Amputation-free survival (AFS) 71% 66 6 3%
Reintervention, amputation, or stenosis (RAS) 39% 43 6 4%
Reintervention or amputation (RAO) 55% 60 6 4%
Limb salvage 84% 85 6 3%
Survival 80% 74 6 3%
Rates reported as freedom from adverse events.overall OPG cohort, as well as between anatomic and clin-
ical high-risk subgroups. ET-speciﬁc regression models for
each OPG end point identiﬁed risk factors for poor
outcome.
Results: 283 CLI patients underwent ET for tissue
loss (77%) or rest pain. Compared to the OPG cohort
(n ¼ 838), patients undergoing ET were more likely to
be >80 years old (32% vs 19%; P < .0001), female (51%
vs 34%; P < .0001), have end stage renal disease (ESRD)
(15% vs 0%; P < .0001), or anatomic high-risk features
(73% vs 60%; P ¼ .002). The mean reintervention rate after
ET was 0.67 per limb-year. The overall effectiveness of ET,
with subgroup analysis, is summarized in the Table.
Conclusions: Although survival-based benchmarks
may be difﬁcult to achieve in “real world” practice that
includes poor surgical candidates and those with ESRD,
most SVS OPGs are attainable with contemporary endo-
vascular therapy. These ﬁndings not only support the role
of ET in the management of CLI, but underscore the
utility of SVS OPGs for comparative effectiveness and
outcomes research.
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Objectives: Determine intervention rates, failure
mechanisms, patency, wound complications and limb
salvage after lower extremity revascularization using open
(OVH) vs endoscopic vein harvest (EVH).
Methods: Single institution review of consecutive
patients between 2005 and 2012, who underwent infrain-
guinal bypass with reversed greater saphenous vein (GSV).to suggested OPGs
Clinical high risk Anatomic high risk
283) OPG (n ¼ 136) Endo (n ¼ 56) OPG (n ¼ 505) Endo (n ¼ 206)
61% 69 6 8% 67% 73 6 5%
53% 60 6 7% 68% 66 6 4%
29% 47 6 8% 36% 56 6 5%
54% 53 6 8% 51% 59 6 5%
80% 82 6 7% 81% 83 6 4%
63% 69 6 7% 80% 77 6 4%
